Product Highlight - Rabeprazole sodium (Rabeloc IV)

13 Sep 2024
Product Highlight - Rabeprazole sodium (Rabeloc IV)
The Innovator Brand of Rabeprazole IV1
5 P’s Action Advantage2


Pace
– Highest pKa: faster activation rate

Power – More effective: 24 hours acid suppression

Precision – Non Enzymatic metabolism: Least drug-drug interaction

Protection – Mucus defense: Mucus secretion & mucin syntheses

Predictability
– Uniform action: Least inter-individual action

References:
1.
IV Rabeprazole in acute erosive GERD & acute bleeding peptic ulcer Cadila Pharmaceuticals Ltd, Dholka, India. Study Code: CPLG1AM1203REG02.
2.
Clinical Study Report IV Rabeprazole in Prevention of Pulmonary Acid Aspiration During Surgery Study Code: IV Rabeprazole by Dr. Amol Wagh, Dr. Sandesh Deolekar; Study Center: Grant Government Medical College and Sir J.J. Group of hospitals, Byculla, Mumbai-400008.
Maharashtra and Dr. D. Y. Patil Hospital and Research Centre, Navi Mumbai-400706. Maharashtra



4th Floor, 393 Goodwill Bldg.,
Senator Gil Puyat Avenue,
Brgy. Bel-Air, Makati City

Related MIMS Drugs